Prognostic Significance of Lymph Node Metastases and Ratio in Esophageal Cancer

Journal of Surgical Research

Volumn 146, Issue 1, 2008, Pages 11-15

  Wilson, Matthew ^a   Rosato, Ernest L ^a   Chojnacki, Karen A ^a   Chervoneva, Inna ^b   Kairys, John C ^a   Cohn, Herbert E ^a   Rosato Sr , Francis E ^a   Berger, Adam C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

esophageal cancer; lymph node ratio; lymph nodes; prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER SURVIVAL; CARDIA; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR LOCALIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES;

EID: 41149083179     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2007.07.028     Document Type: Article

References (13)

1. Jamel A., Murray T., and Ward E. Cancer statistics 2005. CA Cancer J Clin 55 (2005) 10
2. Berger A.C., Farma J., Scott W.J., et al. Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol 23 (2005) 4330
3. Walsh T.N., Noonan N., Hollywood D., et al. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. (See comment; erratum appears in N Engl J Med 1999;341:384). N Engl J Med 335 (1996) 462
4. Hofstetter W., Swisher S.G., Correa A.M., et al. Treatment outcomes of resected esophageal cancer. Ann Surg 236 (2002) 376
5. Korst R.J., Rusch V.W., Venkatraman E., et al. Proposed review of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg 115 (1998) 660
6. Nigro J.J., DeMeester S.R., Hagen J.A., et al. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy. J Thorac Cardiovasc Surg 117 (1999) 960
7. Bollschweiler E., Baldus S.E., Schroeder W., et al. Staging of esophageal carcinoma: Length of tumor and number of involved regional lymph nodes. are these independent prognostic factors?. J Surg Oncol 94 (2006) 355
8. Eloubeidi M.A., Desmond R., Arguedas M.R., et al. Prognostic factors for the survival of patients with esophageal carcinoma in the United States; the importance of tumor length and lymph node status. Cancer 95 (2002) 1434
9. Anne P., Axelrod R., Rosato F., et al. A phase I trial of preoperative paclitaxel, carboplatin, 5-FU, and radiation in patients with resectable esophageal or gastric cancer. J Clin Oncol 22 (2004) 4031
10. Grambsch P., and Therneau T. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81 (1994) 515
11. Refaely Y., and Krasna M.J. Multimodality therapy for esophageal cancer. Surg Clin North Am 82 (2002) 729
12. Enzinger P.C., and Mayer R.J. Esophageal cancer. (See comment). N Engl J Med 349 (2003) 2241
13. Berger A.C., Sigurdson E.R., LeVoyer T., et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes. J Clin Oncol 23 (2005) 8706